Prevail Breakthrough AM
Natural health product licensed in Canada
- Licence holder
- Valentus, Inc.
- NPN or DIN-HM
- 80079063
- Status
- Active licence
- Licence date
- 14 July 2017
- Revision date
- 30 November 2021
- Form
- Poudre pour solution
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Mélange de fruit et légume Source : Blend of Fruit and Vegetable - Edible vegetable part | 1,000 milligramme | Not calculated |
| Inuline Source : Cichorium intybus - racine | 850 milligramme | Not calculated |
| Bacillus coagulans Source : Bacillus coagulans - Cellule entière | 1 Milliards d'UFC | Not calculated |
| Bacillus coagulans Source : Unique IS-2 | 1 Milliards d'UFC | Not calculated |
| Bacillus coagulans Source : Bacillus coagulans - Cellule entière | 5 milligramme | Not calculated |
| Bacillus coagulans Source : Unique IS-2 | 5 milligramme | Not calculated |
| Mélange de fruit et légume Source : Blend of Fruit and Vegetable - Edible fruit part | 1,000 milligramme | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, NA, Lécithine, Caséinate de sodium, Maltodextrines résistantes
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Portion(s) | 1 Tous les jours |
Uses authorised in Canada
Source of antioxidants. Source of probiotics that temporarily modifies gut flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
If hypersensitivity or allergy occurs, discontinue use.
- Contre-indications
If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product.
- Précautions et mises en garde
If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond three days, discontinue use and consult a health care practitioner.
Source
Official Health Canada record, licence 80079063
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging